Function of Myeloid Translocation Gene Related-1
髓样易位基因相关1的功能
基本信息
- 批准号:7600372
- 负责人:
- 金额:$ 32.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-07-01 至 2010-10-30
- 项目状态:已结题
- 来源:
- 关键词:Acute Myelocytic LeukemiaAllelesApoptosisBreastBreast Cancer CellCBFA2T1 geneCancer cell lineCell LineageCell NucleusCellsChemicalsChromosomal translocationCo-ImmunoprecipitationsDNA BindingDataDevelopmentDietEndocrineFamilyFamily memberGene FamilyGene TargetingGenesGeneticGenetic TranscriptionGerm LinesGrowthHematopoietic NeoplasmsHomologous GeneIn VitroIntestinesKnockout MiceMalignant NeoplasmsMediatingMicroinjectionsMusMutagenesisMyelogenousMyeloproliferative diseaseOncogenesPhenotypeProtein FamilyRecruitment ActivityRegulator GenesRegulatory PathwayRoleSignal TransductionSmall IntestinesStem cellsTCF7L2 geneTestingTumor Suppressor ProteinsXenopusadenomabasebeta cateninc-myc Genesdefined contributiongene repressionin vivoinhibitor/antagonistleukemialoss of functionmalignant breast neoplasmprotein functionresearch studyresponseself-renewaltranscription factortumorigenesistumorigenic
项目摘要
DESCRIPTION (provided by applicant): The chromosomal translocations that are closely associated with cancer, most frequently hematopoietic malignancies, disrupt master regulatory genes. Myeloid Translocation Gene Related-1 (MTGR1) is a transcriptional co-repressor that is closely related to 2 genes that are frequently disrupted by chromosomal translocations in acute myeloid leukemia, ETO (MTG8) and MTG16. In addition, LOH of MTG16 is found in up to 40% of the most common form of breast cancer and re-expression of MTG16 impairs the growth of breast cancer cell lines. Thus, the MTG family of co-repressors may function as tumor suppressors. To begin to understand the regulatory pathways that depend on this family of co-repressors, we deleted Mtgr1 from the germ line of mice. These mice are mostly normal, although they are uniformly smaller than their wild-type littermates. However, within their small intestines they have lost the majority of the cell lineage that produces Paneth, goblet, and endocrine cells. Based on this phenotype, we took a candidate approach to test whether DNA binding transcription factors that are required for the normal function of stem cells in the small intestine might recruit Mtgr1. We found that Mtgr1 associates with Tcf4, but not Math1 or Hes1. TCF4 is a DNA binding factor that mediates Wnt signaling in the small intestine. Deletion of Tcf4 in mice causes depletion of the small intestinal stem cell compartment, indicating that Tcf4 is required for stem cell self renewal. TCF4 associates with co-repressors to repress transcription, but in response to Wnt signaling beta-catenin enters the nucleus and dislodges these co-repressors to activate transcription of target genes such as c-Myc. In co-immunoprecipitation experiments Mtgr1 associated with Tcf4, but co-expression of beta-catenin impaired this association, suggesting that Mtgr1 is a negative regulator of Wnt signaling. In addition, we found that the Tcf4-regulated genes c-Myc and Id2 were expressed at higher levels in Mtgr1-null mice, consistent with a role for Mtgr1 as a co-repressor that is recruited by Tcf4. Given that the oncogenes c-Myc and Id2 are over expressed in the small intestines of Mtgr1-null mice and the association of loss of function of MTG family members in leukemia and breast cancer, we hypothesize that MTG family proteins act as tumor suppressors or genetic modifiers of tumor suppressors by negatively regulating Wnt signaling. We will directly test the role of the MTG family in tumorigenesis using a combination of in vitro and in vivo studies.
描述(由申请人提供):与癌症密切相关的染色体易位,最常见的造血恶性肿瘤,破坏主调节基因。髓样转运基因相关1(MTGR1)是一种转录共抑制剂,与2个基因密切相关,这些基因经常受到急性髓样白血病,ETO(MTG8)和MTG16中染色体易位的破坏。此外,在多达40%的乳腺癌形式的40%中发现了MTG16的LOH,MTG16的重新表达会损害乳腺癌细胞系的生长。因此,共抑制剂的MTG家族可能充当肿瘤抑制因子。为了开始理解取决于该共抑制剂家族的调节途径,我们从小鼠的生殖线中删除了MTGR1。这些小鼠大多是正常的,尽管它们比野生型同窝窝小。但是,在其小肠中,他们失去了产生潘妮,杯状和内分泌细胞的大部分细胞谱系。基于这种表型,我们采用了一种候选方法来测试小肠中干细胞正常功能所需的DNA结合转录因子是否可能募集MTGR1。我们发现MTGR1与TCF4相关,而不是Math1或Hes1。 TCF4是介导小肠中Wnt信号传导的DNA结合因子。小鼠中TCF4的缺失会导致小肠干细胞室的耗竭,表明TCF4是干细胞自我更新所必需的。 TCF4与共抑制剂相连以抑制转录,但响应Wnt信号β-catenin进入细胞核,并将这些共抑制剂驱散以激活靶基因(例如C-MYC)的转录。在与TCF4相关的共免疫沉淀实验中,但是β-catenin的共表达损害了这种关联,这表明MTGR1是WNT信号传导的负调节剂。此外,我们发现在MTGR1-NULL小鼠中,TCF4调节的基因C-MYC和ID2在较高水平上表达,这与MTGR1作为TCF4募集的共抑制剂的作用一致。鉴于Oncogenes C-MYC和ID2在MTGR1-NULL小鼠的小肠道中过度表达,并且MTG家族成员在白血病和乳腺癌中的功能丧失缔合,我们假设MTG家族蛋白通过负调控Wnt信号来假设肿瘤抑制剂或肿瘤抑制剂的肿瘤抑制剂。我们将使用体外和体内研究的组合直接测试MTG家族在肿瘤发生中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SCOTT W HIEBERT其他文献
SCOTT W HIEBERT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SCOTT W HIEBERT', 18)}}的其他基金
Role of PRC1 in RUNX1-ETO-mediated transcriptional control
PRC1 在 RUNX1-ETO 介导的转录控制中的作用
- 批准号:
10445091 - 财政年份:2021
- 资助金额:
$ 32.92万 - 项目类别:
Role of PRC1 in RUNX1-ETO-mediated transcriptional control
PRC1 在 RUNX1-ETO 介导的转录控制中的作用
- 批准号:
10298288 - 财政年份:2021
- 资助金额:
$ 32.92万 - 项目类别:
Role of PRC1 in RUNX1-ETO-mediated transcriptional control
PRC1 在 RUNX1-ETO 介导的转录控制中的作用
- 批准号:
10652591 - 财政年份:2021
- 资助金额:
$ 32.92万 - 项目类别:
Regulation of transcription and tumor suppression by MTG family members
MTG 家族成员对转录和肿瘤抑制的调节
- 批准号:
9265416 - 财政年份:2014
- 资助金额:
$ 32.92万 - 项目类别:
Regulation of transcription and tumor suppression by MTG family members
MTG 家族成员对转录和肿瘤抑制的调节
- 批准号:
8696545 - 财政年份:2014
- 资助金额:
$ 32.92万 - 项目类别:
Regulation of transcription and tumor suppression by MTG family members
MTG 家族成员对转录和肿瘤抑制的调节
- 批准号:
9055662 - 财政年份:2014
- 资助金额:
$ 32.92万 - 项目类别:
FASEB SRC on HDACs, Sirtuins and Reversible Acetylation in Signaling and Disease
FASEB SRC 关于 HDAC、Sirtuins 以及信号传导和疾病中的可逆乙酰化
- 批准号:
8595760 - 财政年份:2013
- 资助金额:
$ 32.92万 - 项目类别:
Hdac3 as a therapeutic target in BCL6-dependent lymphoma
Hdac3 作为 BCL6 依赖性淋巴瘤的治疗靶点
- 批准号:
8607465 - 财政年份:2012
- 资助金额:
$ 32.92万 - 项目类别:
Establishing that Hdac3 is a therapeutic target in a subset of B cell Lymphoma
确定 Hdac3 是 B 细胞淋巴瘤亚型的治疗靶点
- 批准号:
9924498 - 财政年份:2012
- 资助金额:
$ 32.92万 - 项目类别:
Hdac3 as a therapeutic target in BCL6-dependent lymphoma
Hdac3 作为 BCL6 依赖性淋巴瘤的治疗靶点
- 批准号:
8230922 - 财政年份:2012
- 资助金额:
$ 32.92万 - 项目类别:
相似国自然基金
等位基因聚合网络模型的构建及其在叶片茸毛发育中的应用
- 批准号:32370714
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于等位基因非平衡表达的鹅掌楸属生长量杂种优势机理研究
- 批准号:32371910
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
基于人诱导多能干细胞技术研究突变等位基因特异性敲除治疗1型和2型长QT综合征
- 批准号:82300353
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACR11A不同等位基因调控番茄低温胁迫的机理解析
- 批准号:32302535
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠杆菌多粘菌素异质性耐药中phoPQ等位基因差异介导不同亚群共存的机制研究
- 批准号:82302575
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
The functional role of DDX41 in myelodysplastic syndromes
DDX41 在骨髓增生异常综合征中的功能作用
- 批准号:
10750070 - 财政年份:2023
- 资助金额:
$ 32.92万 - 项目类别:
Mutant p53 in pathogenesis of Myelodysplastic Syndromes
突变型 p53 在骨髓增生异常综合征发病机制中的作用
- 批准号:
10313142 - 财政年份:2022
- 资助金额:
$ 32.92万 - 项目类别:
Mutant p53 in pathogenesis of Myelodysplastic Syndromes
突变型 p53 在骨髓增生异常综合征发病机制中的作用
- 批准号:
10592239 - 财政年份:2022
- 资助金额:
$ 32.92万 - 项目类别:
Cohesin Mutations in Core-Binding Factor Acute Myeloid Leukemia
核心结合因子急性髓系白血病的粘连蛋白突变
- 批准号:
10430046 - 财政年份:2019
- 资助金额:
$ 32.92万 - 项目类别:
Cohesin Mutations in Core-Binding Factor Acute Myeloid Leukemia
核心结合因子急性髓系白血病的粘连蛋白突变
- 批准号:
10166800 - 财政年份:2019
- 资助金额:
$ 32.92万 - 项目类别: